Survival outcomes of pulmonary metastasis‐directed local therapy in adenoid cystic carcinoma
Open Access
Abstract
Background: Adenoid cystic carcinoma (ACC) frequently has pulmonary metastasis (PM). Given limited systemic therapy options, these metastases are often treated with pulmonary metastasis–directed local therapy (PM‐LT), although with unknown impact on overall survival (OS). This single institution, retrospective cohort study investigated the survival outcomes of PM‐LT versus no PM‐LT in ACC.Methods: ACC patients with at least one PM (≥5 mm) were included. PM‐LT was metastasectomy or radiotherapy. Clinicopathologic characteristics were compared between patients with and without PM‐LT. Primary end point was OS from PM diagnosis, with landmark analysis at 6 months, 1 year, 2 years, and 3 years after metastasis diagnosis, with Cox proportional hazards model multivariate analysis and propensity score matching analysis. Subgroup analysis by ACC histology (solid/nonsolid) was performed.Results: Of 219 included ACC, 119 (54%) had no PM‐LT and 100 (46%) did. PM‐LT patients had more nonsolid histology (p = .0008), oligometastases (p < .0001), exclusively PM (p = .02), and longer time to metastasis from diagnosis (p < .0001). On univariate analysis, PM‐LT by 6 months, 1 year, and 2 years, but not by 3 years, increased OS. On multivariate analysis, PM‐LT by 6 months (p = .12), 1 year (p = .08), or 3 years (p = .08) did not significantly increase OS, but PM‐LT by 2‐years had a borderline statistically significant association (p = .045). Of the 104 nonsolid ACC, 50 underwent PM‐LT and 54 did not. On univariate and multivariate analysis, PM‐LT did not increase OS at any time point for nonsolid ACC.Conclusion: This is the largest study of survival outcomes of PM‐LT in metastatic ACC. Findings suggest PM‐LT does not increase OS in unselected ACC.Keywords
Funding Information
- National Institutes of Health (P30CA016672)
- Adenoid Cystic Carcinoma Research Foundation
This publication has 37 references indexed in Scilit:
- Adenoid Cystic Carcinoma: Clinical and Molecular FeaturesHead and Neck Pathology, 2013
- Adenoid cystic carcinoma of the head and neckCancer, 2012
- Does Surgical Resection of Pulmonary Metastases of Head and Neck Cancer Improve Survival?Annals of Surgical Oncology, 2008
- Lung metastasis resection of adenoid cystic carcinoma of salivary glands☆European Journal of Cardio-Thoracic Surgery, 2008
- Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary glandOral Oncology, 2005
- Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative groupHead & Neck, 2004
- Tumor-doubling time and onset of pulmonary metastasis from adenoid cystic carcinoma of the salivary glandOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1999
- Pulmonary Metastasectomy for Head and Neck CancersAnnals of Surgical Oncology, 1999
- Distant metastasis in adenoid cystic carcinoma of salivary originThe American Journal of Surgery, 1997
- Resection of pulmonary metastases from squamous carcinoma of the head and neckThe American Journal of Surgery, 1988